Frequency of postoperative carotid duplex surveillance and type of closure: Results from a randomized trial  by AbuRahma, Ali F. et al.
1043
From the Department of Surgery, Robert C. Byrd Health
Sciences Center of West Virginia University, Charleston
Division, Charleston Area Medical Center,a and Boehringer
Ingelheim Pharmaceuticals, Inc.b
Competition of interest: nil.
Presented at the Fourteenth Annual Meeting of the Eastern
Vascular Society, Baltimore, Md, May 5-7, 2000.
ORIGINAL ARTICLES
From the Eastern Vascular Society
Frequency of postoperative carotid duplex
surveillance and type of closure: Results
from a randomized trial
Ali F. AbuRahma, MD,a Patrick A. Robinson, MD,b David A. Mullins, MD,a
Steven M. Holt, MD,a Thomas A. Herzog, MD,a and Nathan T. Mowery,
MS IV,a Charleston, WVa, and Ridgefield, Conn
Background/purpose: In several nonrandomized studies investigators have reported on
the value of postoperative carotid duplex surveillance (PCDS) with mixed results; how-
ever the type of closure was not analyzed in these studies. In this study we analyze the
frequency and timing of postoperative carotid duplex ultrasound scanning according to
the type of closure from a randomized carotid endarterectomy (CEA) trial comparing
primary closure (PC) versus patching.
Patient population and methods: We randomized 399 CEAs into 135 PCs, 134 polytetra-
fluoroethylene (PTFE) patch closures, and 130 vein patch closures (VPCs) with a mean
follow-up of 47 months. PCDS was done at 1, 6, and 12 months and every year there-
after (a mean of 4.0 studies per artery). Kaplan-Meier analysis was used to estimate the
rate of ≥ 80% restenosis over time and the time frame of progression from < 50%, to
50%-79% and ≥ 80% stenosis.
Results: Restenoses of ≥ 80% developed in 24 (21%) arteries with PC and nine (4%) with
patching. Kaplan-Meier estimate of freedom of ≥ 80% restenosis at 1, 2, 3, 4, and 5 years
was 92%, 83%, 80%, 76%, and 68% for PC, respectively, and 100%, 99%, 98%, 98%, and
91% for patching, respectively, (P < .01). Of 56 arteries with 20% to 50% restenosis, two
of 28 patch closures and 10 of 28 PCs progressed to 50% to < 80% restenosis (P = .02);
none of the patch closures and six of 28 PCs progressed to ≥ 80% (P = .03). In PCs, the
median time to progression from < 50% to 50%-79%, < 50% to ≥ 80%, and 50%-79% to
≥ 80% was 42, 46, and 7 months, respectively. Of the 24 arteries with ≥ 80% restenosis
in PC, 10 were symptomatic. Thus, assuming that symptomatic restenosis would have
undergone duplex scan examinations regardless, there were 14 asymptomatic arteries
(12%) that could have been detected only with PCDS (estimated cost, $139,200), and
those patients would have been candidates for redo CEA. Of the 9 arteries (3 PTFE clo-
sures and 6 VPCs) with ≥ 80% restenosis with patch closures, 6 asymptomatic (4 VPCs
and 2 PTFE closures) arteries (3%) could have been detected with PCDS. In patients
with normal duplex scan findings at the first 6 months, only four (2%) of 222 patched
arteries (two asymptomatic) developed ≥ 80% restenosis versus five (38%) of 13 in
patients with abnormal duplex scan examination findings (P < .001).
Conclusions: PCDS is beneficial in patients with PC, but is less beneficial in patients with
patch closure. PCDS examinations at 6 months and at 1- to 2-year intervals for several
years after PC are adequate. For patients with patching, a 6-month postoperative duplex
scan examination with normal results is adequate. (J Vasc Surg 2000;32:1043-51.)
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Recurrent carotid artery stenosis is a known
complication following carotid endarterectomy
(CEA), and the frequency of recurrent stenosis
varies depending on the method of diagnosis and
the frequency of follow-up examinations.1-17 There
have been several nonrandomized studies in which
the value of postoperative carotid duplex surveil-
lance (PCDS) has been reported, but no consensus
has been reached concerning the use of PCDS.1-17
Routine use of PCDS has been advocated by some
to detect recurrent stenosis and those patients eligi-
ble for redo CEA. Recently, there have been several
trials in which investigators reported a benign
course of recurrent carotid artery stenosis and a low
probability of future neurologic events. In some of
these studies recurrent stenoses of > 50% in 12% to
36% of the endarterectomized arteries have been
reported.11,13 Despite this high rate of recurrent
stenoses, symptoms attributed to these stenoses
were relatively rare; therefore, several authorities
have suggested that routine surveillance of patients
after CEA is not efficacious.1,2,8,17 Despite these
findings, investigators have been reluctant to advise
that this practice be abandoned because the cost-
effectiveness of this surveillance has not been for-
mally investigated. Others have reported that
high-grade carotid stenosis (> 75% diameter reduc-
tion), whether caused by progressive atherosclerosis
of the contralateral carotid artery or progressive
myointimal hyperplasia of the CEA site, is associ-
ated with an increased risk of late stroke.5,16,18 The
type of closure was not analyzed in these studies.
Therefore, in this study we analyze the frequency
and timing of PCDS according to the type of clo-
sure from a randomized CEA trial comparing pri-
mary closure (PC) versus patching.
PATIENT POPULATION AND METHODS
We randomized 399 CEAs (357 patients) into
135 PCs, 134 polytetrafluoroethylene (PTFE) patch
closures, and 130 vein patch closures (VPCs). This
study was approved by the Institutional Review
Board at our institution. All CEAs were performed
while patients were under general anesthesia with sys-
temic heparin and routine shunting. At the time of
the operation, the normal internal carotid artery dis-
tal to the lesion was measured in millimeters; we used
calipers. All other details of the patient population
and operative technique were described previously.4
All patients were administered aspirin therapy, 325
mg daily, within 24 hours after the operation.
Surveillance protocol. All patients underwent
immediate postoperative color duplex ultrasound
scan that was repeated at 1, 6, and 12 months and
every year thereafter with an ATL Ultramark 9 HDI
system or HDI 3000 system (Advanced Technology
Laboratory, Inc, Bellevue, Wash). A peak systolic
velocity of more than 140 cm/s with spectral broad-
ening throughout systole and an increased diastolic
velocity were consistent with hemodynamically sig-
nificant stenosis of ≥ 50% diameter reduction (with
respect to the diameter of the normal distal internal
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Fig 1. Kaplan-Meier estimate of time to ≥ 80% restenosis.
carotid artery), and a peak systolic velocity of 140
cm/s or more with an end-diastolic velocity of 140
cm/s or more were consistent with ≥ 80% stenosis.19
Restenosis was considered to be present only if the
abnormality detected with duplex ultrasound scan
was not detected on the first immediate PCDS
examination and if it persisted for at least two exam-
inations done within 6 months of the original duplex
scan examination.
Statistical analysis. A Kaplan-Meier analysis was
used to estimate the rate of ≥ 80% restenosis over
time, and the time frame of progression from < 50%,
50% to 79%, and ≥ 80% stenosis. Statistical compar-
isons were made with the Wilcoxon rank sum test.
Statistical comparisons of continuous data were
examined with the unpaired Student t test, and dis-
crete variables were compared with the χ2 or Fisher
exact test.
RESULTS
There were no statistically significant differences
between the demographic and clinical data in
patients with PC and patients with patching.4 The
30-day perioperative results of this series were previ-
ously reported.4 The mean follow-up was 47
months (range, 1-90 months). All 399 carotid arter-
ies underwent long-term follow-up, except for 61
arteries that had only 30-day postoperative duplex
scan results. These included arteries with periopera-
tive carotid thrombosis, patients with perioperative
death, or patients who were lost to follow-up or
refused to have routine duplex surveillance. The
mean number of PCDS studies per artery was 4.0
for the whole series (range: 1-9).
Restenosis of ≥ 80% developed in 24 (21%) of
116 arteries with PC and nine (4%) of 22 with
patching (P < .0001). The Kaplan-Meier estimate of
freedom of ≥ 80% restenosis at 1, 2, 3, 4, and 5 years
was 92%, 83%, 80%, 76%, and 68% for PC, respec-
tively, and 100%, 99%, 98%, 98%, and 91% for patch-
ing, respectively, (P < .01; Fig 1 and Table I). As
noted in Table I, nine arteries with ≥ 80% restenosis
were detected by 12 months in patients with PC,
and eight others were detected by the end of 24
months (ie, 17 [71%] of 24 were detected in 24
months). The Kaplan-Meier estimate of freedom of
50% to 79% restenosis at 1, 2, 3, 4, and 5 years was
92%, 83%, 72%, 72%, and 63% for PC, respectively,
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Table II. Kaplan-Meier life table analysis of time to
50%-79% restenosis according to closure
Time No. at No. Cumulative
interval risk at No. with- Interval patency SE
(mo) start failed drawn patency (%) (%)
Patch
0 222 0 0 1 100 0
6 220 0 2 1 100 0
12 201 2 17 1 99.04 0.68
18 173 1 28 1 98.48 0.92
24 157 0 15 1 98.48 0.97
30 131 2 24 1 97.12 1.44
36 114 0 18 1 97.12 1.54
42 93 0 21 1 97.12 1.71
48 71 0 21 1 97.12 1.96
54 46 0 26 1 97.12 2.43
60 34 0 11 1 97.12 2.83
72 16 0 0 1 97.12 4.12
Primary
0 116 0 1 1 100 0
6 109 3 5 1 97.37 1.51
12 93 6 10 1 91.77 0.68
18 75 5 12 1 86.46 3.09
24 63 3 10 1 82.73 4.33
30 49 6 8 1 74.08 5.39
36 41 1 6 1 72.47 5.94
42 35 0 6 1 72.47 6.43
48 26 0 10 1 72.47 7.46
54 18 1 6 1 68.66 9.06
60 10 1 8 1 62.94 12.12
72 4 0 1 1 44.76 16.63
Table I. Kaplan-Meier life table analysis of time to
≥ 80% restenosis according to closure
Time No. at No. Cumulative
interval risk at No. with- Interval patency SE
(mo) start failed drawn patency (%) (%)
Patch
0 222 0 0 1 100 0
6 220 0 2 1 100 0
12 202 0 18 0 100 0
18 174 1 28 1 99.50 0.53
24 158 1 14 1 98.89 0.83
30 134 2 23 1 97.51 1.33
36 116 0 18 1 97.51 1.43
42 95 0 21 1 97.51 1.58
48 73 0 21 1 97.51 1.80
54 47 2 25 1 93.79 3.41
60 35 1 10 1 91.19 4.58
72 16 0 19 1 91.19 6.77
84 3 2 14 1 75.99 26.33
Primary
0 116 0 1 1 100 0
6 111 4 2 0.991 96.51 1.71
12 97 5 8 1 91.96 2.65
18 79 5 12 1 86.77 3.55
24 68 3 9 0.985 83.19 4.14
30 55 2 10 1 80.48 4.79
36 49 0 6 1 80.48 5.08
42 41 0 8 1 80.48 5.55
48 30 2 9 1 76.18 6.68
54 22 1 8 0.965 72.72 8.10
60 13 1 8 1 67.52 10.67
72 6 1 6 1 61.89 15.60
84 1 0 5 1 61.89 38.21
and 99%, 98%, 97%, 97%, and 97% for patching,
respectively, (P < .01; Table II and Fig 2).
The mean and median time to ≥ 50% restenosis
was 26 and 17 months for the whole series (range,
1-90 months), 21 and 16 months for PC (range, 1-
64), and 37 and 24 months for patching (range, 7-
90). The mean and median time to ≥ 80% restenosis
was 27 and 18 months for the whole series (range,
1-90), 24 and 17 months for PC (range, 1-83), and
43 and 27 months for patching (range, 7-90).
Of 56 arteries with < 50% restenosis, two (7%) of
28 patch closures and 10 (36%) of 28 PCs pro-
gressed to 50%-79% restenosis (P = .02), and none
of the 28 patch closures and six (21%) of 28 PCs
progressed to ≥ 80% stenosis (P = .03). Of 38 arter-
ies that were reported to have 50% to 79% stenosis,
one (13%) of eight patch closures and six (20%) of
30 PCs subsequently progressed to ≥ 80% stenosis.
Only one of nine patched arteries showed progres-
sion before becoming ≥ 80% stenoses; one of these
was total occlusion.
In the PC group, the median time to progression
from < 50% to 50%-79%, from < 50% to ≥ 80%, and
from 50% to 79% to < 80% to ≥ 80% was 42, 46, and
7 months, respectively. Tables III and IV summarize
the time to progression of restenosis for the whole
series and for PC, respectively. Table V summarizes
the progression of restenosis from one degree to
another according to the type of closure. Table VI
shows the correlation between ≥ 80% restenosis and
neurologic events (ipsilateral hemispheric transient
ischemic attacks [TIAs] or strokes) in the whole
group, and patients with patch closure and PC.
When the results of the first 6-month PCDS
examinations were analyzed, 209 (94%) of 222
arteries with patching had a PCDS examination with
normal results, four of which (2%) had ≥ 80%
restenosis (two asymptomatic, one total occlusion,
and one symptomatic patients). In contrast, five
(38%) of 13 arteries had abnormal PCDS examina-
tion findings, and they developed ≥ 80% restenosis
(P < .001). In patients with PC, 76 (66%) of 116
arteries had a PCDS examination with normal
results, and four (5%) of these developed ≥ 80%
restenosis. In contrast, 20 (50%) of 40 arteries had a
PCDS examination with abnormal results and devel-
oped ≥ 80% restenosis (P < .001).
Of the 24 arteries with PC that developed ≥ 80%
restenosis, ten were symptomatic. Thus, assuming
that patients with symptomatic restenosis would have
undergone a duplex scan examination anyway, there
were 14 asymptomatic arteries (12%) (one of these
had total occlusion) that could have been detected
only with PCDS, and they were candidates for redo
CEAs. Of the nine arteries with ≥ 80% restenosis with
patch closures (three PTFE closures and six VPCs),
six (3%) were asymptomatic, one of which was a total
occlusion, (four VPCs and two PTFE closures) and
could have been detected only with PCDS.
The estimated total cost of PCDS for detecting
the 14 asymptomatic arteries in patients with PC was
$139,200 (a mean four studies per artery, multiplied
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Fig 2. Kaplan-Meier estimate of time to 50%-79% restenosis according to closure.
by 116 arteries at a cost of $300.00 per study). On
the basis of this protocol of post-CEA surveillance
followed by a redo CEA for ≥ 80% recurrent
stenoses, it is expected that 14 repeat CEAs would
have been required for a total cost of $224,600
($85,400 for both hospital and physician Medicare
reimbursement for 14 CEAs and $139,200 for the
cost of PCDS). Assuming a 5% stroke rate for repeat
CEAs,20 0.7 strokes would be associated with the 14
repeat CEAs, and approximately 4.7 strokes would
have been prevented through surgical intervention
for 14 arteries with ≥ 80% restenoses before occlu-
sion (assuming a similar outcome of ≥ 80% resteno-
sis as described by Mattos et al1), for a net reduction
of four strokes in patients with PC and an approxi-
mate cost of $56,150 per stroke prevented.
DISCUSSION
Recurrent carotid artery stenosis is a known
process following CEA and has been described by
numerous authors.1-18 In many past studies out-
comes and recommendations for PCDS have been
reported. The advantage cited was the detection of
significant recurrent carotid artery stenosis before
the onset of neurologic symptoms to prevent poten-
tial stroke and to follow the contralateral carotid
artery for development of surgically correctable
stenosis. Opponents of routine PCDS claim a
benign nature to recurrent carotid artery stenosis
and therefore, a low incidence of stroke preven-
tion.1,2,5-9,17 As yet, a consensus has not been
reached in the surgical literature regarding the use-
fulness, cost-effectiveness, or timing of PCDS.
Previous trials have concluded that the need for
PCDS is minimal, secondary to the benign nature of
recurrent carotid artery stenosis. Mattos et al1
described their experience with PCDS and found
equal stroke-free survival at 5 years between patients
with and without recurrent stenosis (> 50%). In addi-
tion, only one of 380 patients had a stroke in their
study, suggesting a benign clinical significance of
recurrent carotid artery stenosis. With these results,
the authors suggested an initial 6-month duplex scan
examination and subsequent yearly surveillance
examinations.1 Mackey et al2 claimed a low rate of
clinically significant recurrent carotid artery stenosis.
Their retrospective series of 258 patients (348 arter-
ies) showed a potential 4% incidence of late strokes,
but included all patients who underwent repeat CEA
for asymptomatic recurrent stenosis. They also noted
that most of their recurrent stenoses (53%) remained
asymptomatic and did not progress to occlusion
throughout follow-up. Of 10 documented late
occlusions, eight did not result in stroke. Eight
patients with operable recurrent stenoses had TIAs
and underwent reoperation. They also noted that
even patients with 75% to 99% recurrent stenoses
most often remained symptom free (37%) or had
TIAs (32%). Only two (11%) of 19 patients with 75%
to 99% recurrent stenoses had an unheralded stroke.
They thought that PCDS was not justified with the
low incidence of symptomatic restenosis.
Ouriel and Green3 reported an 11% incidence of
restenotic lesions greater than 80%. Although the
incidence of symptoms with restenotic lesions was
low (12%), the onset of symptoms at the time of
occlusion was significant. Forty-two percent of
patients became symptomatic at the time of occlusion
from recurrent carotid artery stenosis with 33% of
those resulting in a stroke. This led to the observa-
tion that critical restenotic lesions are precursors to
stroke, even if asymptomatic, and therefore, the
detection of stenosis of > 80% on a carotid artery that
was previously operated on would allow for future
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Table III. Time to progression of restenosis for the whole series (in months)
Progression of restenosis Minimum Maximum Median Mean SEM
From < 50% to 50%-79% 14 75 42 37 6
From < 50% to ≥ 80% 14 50 45 39 6.9
From 50%-79% to ≥ 80% 2 26 6 9 3
Table IV. Time to progression of restenosis for patients with PC (in months)
Progression of restenosis Minimum Maximum Median Mean SEM
From < 50% to 50%-79% 14 75 42 37 6.6
From < 50% to ≥ 80% 14 50 45 39 6.9
From 50%-79% to ≥ 80% 2 26 7 10 3.5
stroke prevention if operative intervention was
undertaken.3 Mattos et al1 also described the out-
comes for > 80% recurrent stenosis. In their group of
patients, one of three patients with > 80% recurrent
stenosis had a stroke, one had a TIA, and one
remained asymptomatic. This suggests a more seri-
ous course once recurrent stenosis reaches > 80%.1,3
We have presented the data concerning resteno-
sis after CEA from our prospective randomized trial
comparing PC with patch angioplasty.4 In this group
of patients, there was an overall incidence of recur-
rent stenosis of 34% for PC, 2% for PTFE patch clo-
sure, and 9% for VPC. Recurrent stenosis in this
series was defined as > 50%. In addition, there was a
higher number of patients who required redo
carotid surgery for the PC group (11% versus 1%-2%
for patch closure). For the purpose of this study, we
are defining significant recurrent carotid stenosis as
> 80% stenosis and attempting to define the best sur-
veillance regimen for PCDS.4
In considering the timing of PCDS, several
authors have recommended an initial surveillance
duplex scan on the operative carotid system within
the first 6 months.1-3,5,7,9,12 This is to detect residual
stenosis from the operative procedure or early
restenosis.3 For example, Roth et al5 recently recom-
mended an initial duplex ultrasound scan to ensure a
technically successful CEA with subsequent PCDS at
1 to 2 years as long as recurrent and contralateral
stenoses remain < 50%. More frequent follow-up
(every 6 months) is warranted if > 50% stenosis is
noted or if there is the onset of symptomatic disease.
In several studies investigators have reported
that most recurrent stenoses occur during the first 1
to 2 years after CEA. Zierler et al11 noted that 91%
of restenoses occur during the first year. Mattos et
al7 also noted that 70% of restenoses were detected
within 1 year after the CEA, and 96% developed
within 15 months. Thomas et al14 reported that
70% of restenoses in their study occurred within 1
year of the CEA. Similar observations were noted
by us previously.4
There was only a 2% incidence of detecting
recurrent stenosis of > 80% in our patients who were
treated with a patch angioplasty closure and who
had normal findings from a PCDS at 6 months.
Therefore, once the initial 6-month PCDS has nor-
mal results, no further PCDS is necessary in the
patch angioplasty group. In the patch angioplasty
group, our results show that only six of 222 asymp-
tomatic patients had > 80% restenosis versus 14 of
116 in the PC group.
There have been reports that PCDS is not cost-
effective because there is such a low incidence of
symptomatic recurrent carotid artery stenosis. Patel et
al6 evaluated the cost-effectiveness of PCDS. They
concluded that PCDS after CEA has an unfavorable
cost-effectiveness ratio. In the process of their analy-
sis, they identified a subset of patients in whom PCDS
may be cost-effective. These included those patients
in whom the rate of progression to > 80% stenosis
exceeded 6% per year. In their analysis, they thought
that some groups of patients could potentially have a
rate of disease progression that approaches or exceeds
the level at which PCDS becomes cost-effective.
Some of these include patients with multiple risk fac-
tors (eg, hyperlipidemia, diabetes mellitus, smoking,
hypertension, coronary artery disease, female sex, and
a young age).6 In addition, they concluded that with
PCDS, the rate of carotid artery occlusion could be
reduced by 15% per year.6 Our evaluation of the cost
of PCDS agrees with these conclusions.
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Table V. Progression of restenosis/type of closure
Progression Patch closure PC Total
From < 50% to 50%-79% Yes 2 (7%)* Yes 10 (36%)* 12 (21%)
No 26 (93%) No 18 (64%)
Total 28 28 56
χ2 5.197
From < 50% to ≥ 80% Yes 0† Yes 6 (21%)† 6 (11%)
No 28 (100%) No 22 (79%)
Total 28 28 56
χ2 4.667
From 50%-79% to ≥ 80% Yes 1 (13%)‡ Yes 6 (20%)‡ 7 (18%)
No 7 (87%) No 24 (80%)





Assuming a 5% stroke rate for the 14 repeat
CEAs in the PC group in our series for asympto-
matic ≥ 80% restenosis,20 0.7 strokes would be asso-
ciated with the 14 repeat CEAs, and approximately
4.7 strokes would have been prevented through sur-
gical intervention before occlusion (assuming a sim-
ilar outcome of ≥ 80% restenosis as described by
Mattos et al1). This would result in a net reduction
of four strokes in patients with PC and an approxi-
mate cost of $56,150 per stroke prevented, as
described in the “Results” section.
Also, assuming a similar outcome of > 80%
restenosis as described by Ouriel and Green,3 and if
one half of these > 80% restenosis would progress to
total occlusion (seven patients), and assuming one
third of patients with total occlusion would have a
stroke, then approximately 2.3 strokes would be pre-
vented by doing the 14 redo CEAs. Because 0.7
strokes would result from repeating 14 CEAs,20 the
net effect would be prevention of 1.6 strokes at a
cost of $224,600 (ie, $140,250 per stroke pre-
vented). This analysis does not take into considera-
tion the value of duplex screening of the
contralateral nonoperated side.
The justification for this cost is unclear without a
definite estimate of the economic burden for caring
for these patients who have had strokes. Considering
the low incidence of > 80% restenosis in patients
with patch angioplasty closure, the cost-effectiveness
of PCDS appears to be unfavorable and, therefore,
should be limited to a single duplex ultrasound scan
to detect residual stenosis. Subsequent follow-up
should be dictated by the results found on the initial
scan and the onset of neurologic symptoms.
This randomized prospective study confirms that
carotid restenosis is a known entity that follows a per-
centage of patients who undergo carotid surgery. In
the past, the clinical significance of carotid restenosis
has led some investigators to conclude that PCDS
was not warranted. This is the largest randomized
prospective trial comparing PC versus patch closure.
We show that on the basis of the incidence of > 80%
restenosis, PCDS may be beneficial in patients with
PC with examinations at 6 months and at 1- to 2-
year intervals for several years. For patients with
patching, a 6-month postoperative duplex scan
examination with normal results is adequate.
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Dr Thomas S. Riles (New York, NY). Thank you for
the opportunity to discuss this. 
Dr AbuRahma and his colleagues are to be congratu-
lated for an excellent paper and presentation and a very well-
written manuscript. I’ve had the opportunity to go through
it, and there is a lot of important information for all of us. 
Although earlier papers have demonstrated the benefit
of carotid patching in preventing recurrent stenosis, your
study is a landmark work because the patients were
prospectively randomized. It is also a large series, and
there is excellent long-term follow-up. This study should
convince the most skeptical that recurrent stenosis is
greatly reduced by patch closure. Unfortunately, I’m sure
the debate will go on for many years to come. 
The focus of this report is the efficacy of postoperative
surveillance studies, specifically duplex scans, for the detec-
tion of recurrent carotid stenosis. As you saw in the last
slide, the authors have concluded from their analysis that
beyond an initial study at 6 months after carotid surgery,
routine periodic scanning may be cost-effective if the artery
was closed primarily, but was not justified for patch closures
since the incidence of restenosis was so small. Although
their argument is quite persuasive, there are several ques-
tions that need to be addressed before their recommenda-
tions can be accepted as a practice standard. 
First, what about the other side? Isn’t it true that
patients who have had carotid endarterectomy have a 5% to
10% chance of developing contralateral stenosis requiring
surgery during their remaining years? If this additional risk
is taken into consideration, wouldn’t the benefit of routine
postoperative surveillance studies be greatly increased? 
Secondly, we know that recurrent stenosis may be due
to either intimal hyperplasia or atherosclerosis. Neointimal
hyperplasia is an early lesion usually occurring during the
first year or two after surgery. Atherosclerosis, on the
other hand, takes much longer to develop. It is rarely seen
during the first 4 years and may not become a clinical
problem for 8 to 20 years after carotid endarterectomy.
Also, from our experience, atherosclerosis affects patched
arteries just as frequently as it does primary closed arteries.
Since your mean follow-up is only 4 years, few of your
patients have had time to develop atherosclerotic lesions.
Don’t you think it’s a bit premature to state flatly that
there is no benefit to continued surveillance beyond 6
months for patch arteries? 
Finally, some authors have advocated abbreviated and
less costly duplex scans for postoperative surveillance. One
paper even calls for the resurrection of the OPG—for you
young faces in the audience, that’s an oculoplethysmogra-
phy that we used to use—for follow-up studies to reduce
the cost. Have you considered lower cost follow-up stud-
ies? If the cost of postoperative surveillance was less,
would this change your conclusions? 
Again, congratulations on this fine study, and I thank
the Society for the opportunity to discuss it. Thank you. 
Dr Ali F. AbuRahma. Thank you, Tom. I totally agree
with you on the value of duplex ultrasound on the con-
tralateral side. This was not addressed in our study for the
DISCUSSION
simple reason that more authorities agree on the value of
duplex ultrasound for examining the contralateral side, par-
ticularly in the presence of stenosis. However, the value of
duplex ultrasound in postcarotid endarterectomy surveil-
lance is questionable, and that was the main objective of
our study. Definitely, if we add the value of duplex ultra-
sound on the follow-up of the contralateral stenoses, then
the outcome analysis would be somewhat different. In
regard to your second question about neointimal hyperpla-
sia versus atherosclerosis, you could follow these patients
for several years prior to seeing the effect of atherosclero-
sis; however, we don’t believe it would be practical to per-
form these tests hoping to detect the atherosclerotic lesions
in the future. Finally, in regard to advocating less cost of
the duplex scan for postoperative surveillance (ie, using
OPG), I understand the limited value of OPG in this
regard. We have concluded in past studies that an OPG is
helpful in patients with acute postoperative carotid throm-
bosis if used in the operating room immediately after a
carotid endarterectomy.
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